Adverse events 2.0-Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology

Eur J Cancer. 2019 May:112:29-31. doi: 10.1016/j.ejca.2019.01.015. Epub 2019 Mar 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / immunology*
  • Autoimmune Diseases / immunology
  • Drug-Related Side Effects and Adverse Reactions / immunology*
  • Humans
  • Immunotherapy / methods
  • Neoplasms / immunology
  • Neoplasms / therapy

Substances

  • Antineoplastic Agents